Adocia SA ADOCY Stock
Adocia SA Price Chart
Adocia SA ADOCY Financial and Trading Overview
| Adocia SA stock price | 11.8 USD |
| Previous Close | 11.8 USD |
| Open | 11.8 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 11.8 - 11.8 USD |
| 52 Week Range | 11.8 - 11.8 USD |
| Volume | 200 USD |
| Avg. Volume | 0 USD |
| Market Cap | 170.44M USD |
| Beta (5Y Monthly) | 0.856 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ADOCY Valuation Measures
| Enterprise Value | 166.36M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 28.17584 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 27.502 |
| Enterprise Value/EBITDA | -12.103 |
Trading Information
Adocia SA Stock Price History
| Beta (5Y Monthly) | 0.856 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 32.69% |
| 52 Week High | 11.8 USD |
| 52 Week Low | 11.8 USD |
| 50-Day Moving Average | 11.8 USD |
| 200-Day Moving Average | 11.8 USD |
ADOCY Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 14.44M |
| Float | 10.54M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2023 |
| Most Recent Quarter (mrq) | December 31, 2023 |
| Next Fiscal Year End | December 31, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -323.32% |
| Gross Margin | -223.82% |
| EBITDA Margin | -227.22% |
Management Effectiveness
| Return on Assets (ttm) | -32.039% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 6.05M USD |
| Revenue Per Share (ttm) | 0.55 USD |
| Quarterly Revenue Growth (yoy) | -69.099% |
| Gross Profit (ttm) | -13539000 USD |
| EBITDA | -13745000 USD |
| Net Income Avi to Common (ttm) | -21162000 USD |
| Diluted EPS (ttm) | -3.51 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 12.96M USD |
| Total Cash Per Share (mrq) | 0.92 USD |
| Total Debt (mrq) | 13.09M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.02 |
| Book Value Per Share (mrq) | -0.491 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4950000 USD |
| Levered Free Cash Flow (ttm) | 884.63K USD |
Profile of Adocia SA
| Country | United States |
| State | N/A |
| City | Lyon |
| Address | 115 Avenue Lacassagne |
| ZIP | 69003 |
| Phone | 33 4 72 61 06 10 |
| Website | https://www.adocia.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 78 |
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; and BioChaperone LisPram, a combination of prandial insulin with pramlintide, as well as M1Pram, a combination of insulin M1 and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and AdoGel Sema for the long-term delivery of therapeutic agents. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.
Q&A For Adocia SA Stock
What is a current ADOCY stock price?
Adocia SA ADOCY stock price today per share is 11.8 USD.
How to purchase Adocia SA stock?
You can buy ADOCY shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Adocia SA?
The stock symbol or ticker of Adocia SA is ADOCY.
Which industry does the Adocia SA company belong to?
The Adocia SA industry is Biotechnology.
How many shares does Adocia SA have in circulation?
The max supply of Adocia SA shares is 14.44M.
What is Adocia SA Price to Earnings Ratio (PE Ratio)?
Adocia SA PE Ratio is 0.00000000 now.
What was Adocia SA earnings per share over the trailing 12 months (TTM)?
Adocia SA EPS is 0 USD over the trailing 12 months.
Which sector does the Adocia SA company belong to?
The Adocia SA sector is Healthcare.